Home > Compound List > Compound details
42200-33-9 molecular structure
click picture or here to close

(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol

ChemBase ID: 1073
Molecular Formular: C17H27NO4
Molecular Mass: 309.40058
Monoisotopic Mass: 309.19400835
SMILES and InChIs

SMILES:
O[C@@H]1[C@H](O)Cc2c(C1)c(OCC(O)CNC(C)(C)C)ccc2
Canonical SMILES:
OC(COc1cccc2c1C[C@H](O)[C@@H](C2)O)CNC(C)(C)C
InChI:
InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1
InChIKey:
VWPOSFSPZNDTMJ-UCWKZMIHSA-N

Cite this record

CBID:1073 http://www.chembase.cn/molecule-1073.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
IUPAC Traditional name
nadolol
Brand Name
Anabet
Corgard
Solgol
Synonyms
Nadolol
Nadolol
(2R,3S)-5-[3-(tert-butylamino)-2-hydroxypropoxy]-1,2,3,4-tetrahydronaphthalene-2,3-diol
纳多洛尔
CAS Number
42200-33-9
EC Number
255-706-3
MDL Number
MFCD00079476
PubChem SID
46505509
24897535
160964536
PubChem CID
39147
ATC CODE
C07AA12
CHEMBL
649
Chemspider ID
35815
DrugBank ID
DB01203
IUPHAR ligand ID
554
KEGG ID
D00432
Unique Ingredient Identifier
FEN504330V
Wikipedia Title
Nadolol
Medline Plus
a682666

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 13.586201  H Acceptors
H Donor LogD (pH = 5.5) -2.3368313 
LogD (pH = 7.4) -1.4429477  Log P 0.8654279 
Molar Refractivity 85.5269 cm3 Polarizability 33.76481 Å3
Polar Surface Area 81.95 Å2 Rotatable Bonds
Lipinski's Rule of Five true 
Log P 1.23  LOG S -2.14 
Solubility (Water) 2.25e+00 g/l 

PROPERTIES

PROPERTIES

Physical Property Safety Information Pharmacology Properties Product Information Bioassay(PubChem)
Solubility
8330 mg/L expand Show data source
Hydrophobicity(logP)
0.379 expand Show data source
1.2 expand Show data source
RTECS
QJ4870000 expand Show data source
MSDS Link
Download expand Show data source
German water hazard class
2 expand Show data source
Personal Protective Equipment
Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter expand Show data source
Admin Routes
Oral expand Show data source
Excretion
Renal and fecal (unchanged) expand Show data source
Half Life
14-24 hours expand Show data source
Metabolism
Nil expand Show data source
Protein Bound
30% expand Show data source
Legal Status
POM (UK) expand Show data source
Rx-only (US) expand Show data source
Pregnancy Category
C (US) expand Show data source
Gene Information
human ... CYP1A2(1544) expand Show data source
Purity
95% expand Show data source
Grade
analytical standard expand Show data source
Empirical Formula (Hill Notation)
C17H27NO4 expand Show data source

DETAILS

DETAILS

DrugBank DrugBank Wikipedia Wikipedia Sigma Aldrich Sigma Aldrich
DrugBank - DB01203 external link
Item Information
Drug Groups approved
Description A non-selective beta-adrenergic antagonist with a long half-life, used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension. Nadolol is also used for migraine disorders and for tremor. [PubChem]
Indication Used in cardiovascular disease to treat arrhythmias, angina pectoris, and hypertension.
Pharmacology Nadolol is a nonselective beta-adrenergic receptor antagonist with a long half-life, and is structurally similar to propranolol. Clinical pharmacology studies have demonstrated beta-blocking activity by showing (1) reduction in heart rate and cardiac output at rest and on exercise, (2) reduction of systolic and diastolic blood pressure at rest and on exercise, (3) inhibition of isoproterenol-induced tachycardia, and (4) reduction of reflex orthostatic tachycardia. Nadolol has no intrinsic sympathomimetic activity and, unlike some other beta-adrenergic blocking agents, nadolol has little direct myocardial depressant activity and does not have an anesthetic-like membrane-stabilizing action.
Toxicity Oral, mouse: LD50 = 4500mg/kg. Symptoms of overdose include abdominal irritation, central nervous system depression, coma, extremely slow heartbeat, heart failure, lethargy, low blood pressure, and wheezing.
Affected Organisms
Humans and other mammals
Biotransformation Not metabolized by the liver and excreted unchanged primarily by the kidneys.
Absorption Absorption of nadolol after oral dosing is variable, averaging about 30 percent.
Half Life 14-24 hours
Protein Binding 30%
Elimination Unlike many other beta-adrenergic blocking agents, nadolol is not metabolized by the liver and is excreted unchanged, principally by the kidneys. Nadolol is excreted predominantly in the urine.
External Links
Wikipedia
RxList
PDRhealth
Drugs.com
Sigma Aldrich - N1892 external link
Biochem/physiol Actions
β-Adrenergic blocker

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
    No data available
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle